US drug industry's guidelines on advertising too limited, say critics

BMJ 2005; 331 doi: (Published 18 August 2005) Cite this as: BMJ 2005;331:420
  1. Bob Burton
  1. Canberra

    In the face of growing support for tighter regulations on advertising directly to consumers, the US drug industry's trade association has released voluntary guidelines of its own.

    However, the guidelines fall short of a proposal by the leader of the Republican Senate majority, Bill Frist, for a two year waiting period before any new drug can be advertised directly to consumers. In July Dr …

    View Full Text

    Log in

    Log in through your institution


    * For online subscription